MREO vs BIIB: Which Stock is Better?
Side-by-side comparison of Mereo BioPharma Group PLC ADR and Biogen Inc in 2026
MREO
Mereo BioPharma Group PLC ADR
$0.57
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | MREO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | 0.0% | 0.0% | BIIB |
| Gross Margin | 73.4% | 76.6% | BIIB |
Analyze MREO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or BIIB a better investment?
Comparing MREO and BIIB: Mereo BioPharma Group PLC ADR has a market cap of $89.93M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and BIIB?
MREO (Mereo BioPharma Group PLC ADR) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or BIIB?
BIIB has higher revenue growth at 0.0% vs 0.0% for MREO.
Which company is more profitable: MREO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to 73.4% for MREO.
Which is the larger company: MREO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $89.93M for MREO.
Should I buy MREO or BIIB in 2026?
Both MREO and BIIB have investment merit. MREO trades at $0.57 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and BIIB stock?
Key differences: Market Cap ($89.93M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (73.4% vs 76.6%).